Ophthalmology Grand Rounds: Autoimmune Retinopathies
via Webex
When |
October 22, 2021
7 a.m. to 8 a.m.
Grand rounds is mainly a case-based CME conference representing all areas of ophthalmology. Residents and fellows present common and uncommon cases with interesting clinical questions and a faculty moderator will facilitate the discussion. The aim of the conference is to educate the audience on clinical pearls, best practices, quality improvement, and examining the contemporary evidence. Target audience: Ophthalmologists and ophthalmologists in training. Talk title: “Autoimmune Retinopathies” Speakers: Grazyna Adamus, Ph.D. Learning objectives: Participants will be able to:
Accreditation Oregon Health & Science University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physician Credits OHSU School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Disclosure to LearnersPresenters/Moderators
Program Planning Committee
|
---|---|
Where |
When it's time, join your Webex meeting here. Phone (audio only): Mobile phone (one-touch): |
Contact Information |
Grand rounds is mainly a case-based CME conference representing all areas of ophthalmology. Residents and fellows present common and uncommon cases with interesting clinical questions and a faculty moderator will facilitate the discussion. The aim of the conference is to educate the audience on clinical pearls, best practices, quality improvement, and examining the contemporary evidence.
Target audience: Ophthalmologists and ophthalmologists in training.
Talk title: “Autoimmune Retinopathies”
Speakers:
Grazyna Adamus, Ph.D.
Paul Yang, M.D., Ph.D.
Learning objectives:
Participants will be able to:
- Discuss autoimmune retinopathy and paraneoplastic retinopathies.
- Discuss the utility of screening for anti-retinal autoantibodies from clinical specimens.
- Evaluate technologies available to screen for anti-retinal autoantibodies for retinal diseases.
Accreditation
Oregon Health & Science University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physician
Credits
OHSU School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure to Learners
Presenters/Moderators
- Grazyna Adamus, Ph.D. - Nothing to Disclose
- Paul Yang, M.D., Ph.D. - Nothing to Disclose
Program Planning Committee
- Hemakshi Adke - Nothing to Disclose
- Aiyin Chen, M.D. - Nothing to Disclose
- Julie Falardeau, M.D. - Nothing to Disclose
- Thomas Hwang, M.D. - Nothing to Disclose
- Lauren Jensen, M.D. - Nothing to Disclose
- Susan Minnieweather - Nothing to Disclose
- Afshan Nanji, M.D. - Nothing to Disclose
- Leah Reznick, M.D. - Nothing to Disclose
- Daniel Tu, M.D., Ph.D. - Nothing to Disclose